Key points are not available for this paper at this time.
Our findings suggest that dementia has a substantial impact on direct costs in Parkinson's disease, mainly due to high costs for institutional care. In addition, there were indications that even patients with mild cognitive impairment have higher nonmedical costs.
Vossius et al. (Fri,) studied this question.